期刊文献+

产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌耐药性分析 被引量:5

Drug resistance analysis for Klebsiella pneumoniae and Escherichia coli with ESBLs
原文传递
导出
摘要 目的:了解我院产ESBLs肺炎克雷伯菌和大肠埃希菌在不同临床标本中的分布及耐药性。方法:采用CLSI推荐的双纸片协同试验。用头孢他啶、头孢他啶/克拉维酸和头孢噻肟、头孢噻肟/克拉维酸确证试验确认,检测我院2006年6月至2008年6月临床标本中分离出的85株产ESBLs肺炎克雷伯菌和156株产ESBLs大肠埃希菌。用K-B法进行药物敏感试验,并用上海新和实验室管理软件分析细菌分布和耐药性。结果:我院产ESBLs肺炎克雷伯菌在痰、咽试子、胸腹水、分泌物、胆汁、脓液、尿液中的检出率分别为42.2%、29.6%、17.9%、28.6%、30.8%、25.6%,产ESBLs大肠埃希菌在上述标本中检出率分别为33.3%、28.2%、43.6%、31.6%、25.0%、24.3%。各类标本中检出的产ESBLs肺炎克雷伯菌和大肠埃希菌均对亚胺培南敏感,对广谱青霉素类和头孢类抗生素耐药率高。结论:产ESBLs肺炎克雷伯菌和大肠埃希菌可分布于临床各种标本中,它们是β-内酰胺类抗生素耐药的重要机制。因此及时准确地检出ESBLs菌株对临床合理使用抗生素、防止细菌耐药性产生及控制耐药菌的播散和流行均有重要意义。 Objective:To study the distribution and drug resistance of Klebsiella pneumoniae and Escherichia coli with ESBLs in our hospital various clinical samples. Methods: Using double disk synergy test recommended by CLSI, which contained Ceftazidime, Ceftazidime/Clavulanic acid and Cefotaxime, Cefotaxime/Clavulanic acid, to detected 85 strains of Klebsiella pneumoniae and 156 strains of Escherichia coil with ESBLs isolated from clinical samples of our hospital during June 2006 - June 2008. The K - B assay was used for drug sensitivity test and the Lab management software producted by Shanghai Xinhe was used to analysis the distribution and drug resistance of the tow bacteria. Results:The detection rates of Klebsiella pneumoniae with ESBLs were 42. 2%, 29.6%, 17.9%, 28.6%, 30. 8% and 25.6% in sputum, throat swab, pleural and abdominal dropsy, secretion, bile, liquor purls and urine respectively, and the rates of Escherichia coli with ESBLs were 33.3% ,28.2% ,43.6% ,31.6%, 25.0% ,24. 3% in above samples. Both of tow bacteria were sensitive to Imipenem and had high drug resistance to broad - spectrum penicillins and Cephalosporins. Conclusion:Klebsiella pneumoniae and Escherichia coli with ESBLs exist in mamy clinical samples, and are major reasons for β- lactam antibiotics resistance. Therefore, quick and exact identification of the two bacteria is important for rational use of antibiotics, prevention of drug resistance and control of prevalence of drug - resistance bacteria.
出处 《中国卫生检验杂志》 CAS 2009年第4期872-873,918,共3页 Chinese Journal of Health Laboratory Technology
关键词 ESBLs肺炎克雷伯菌 ESBLs大肠埃希菌 耐药性 分布 Klebsiella pneumoniae with ESBLs Escherichia coli with ESBLs Drug resistance Distribution
  • 相关文献

参考文献5

  • 1陈民钧,王辉,中国医院内病原菌耐药监测网.中国重症监护病房革兰阴性菌耐药性连续7年监测研究[J].中华医学杂志,2003,83(5):375-381. 被引量:504
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibilitytests. 6th ed. Approved standard M2 - A6 ( M100 - S7 ). Wayne: NCCLS,2003.
  • 3邵良荣,王国政,孙明中,居会祥.产ESBLs阴沟肠杆菌的临床分布及耐药性研究[J].中华医院感染学杂志,2006,16(1):105-106. 被引量:16
  • 4WeinsteinRA.产β-内胺酶耐药菌-全球性难题.急救快车,2002,8:18-18.
  • 5Chanawong A, Xiong L, Hawkey PM,et al. Three cefotaximasea, CTX- M -9, CTX - M - 13, CTX - M - 14, among enterobactericeae in the peoples republic of China [ J ]. Antimicrob Agents Chemother,2002,46(3):630 -637.

二级参考文献13

  • 1Ferraro MJ,Gaig WA,Dudley MM,etal.Performance standards for antimicrobial susceptibility testing[S].Ninth informational supplement.NCCLS,1999.19(1):28.
  • 2Quinteros M,Adice M,Gardella N,etal.Extended-spectrum beta-lactamases in Enterobacteriaceae in Buenos Aires,Argentina,public hospitals[J].Antimicrob Agents Chemother,2003,47(9):2864-2867.
  • 3Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 4Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 5Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 6Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 7National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 8Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 9朱戌冬,徐英春,吴伟元,王辉,陈民钧.一种新CTX-M型超广谱β-内酰胺酶及其临床意义[J].中华检验医学杂志,2001,24(4):207-210. 被引量:47
  • 10王辉,吴伟元,陈民钧.肠杆菌科细菌中超广谱β-内酰胺酶(ESBL)的研究[J].中华微生物学和免疫学杂志,2001,21(6):676-679. 被引量:99

共引文献518

同被引文献40

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部